Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (34) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Direct healthcare professional communication (18) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (1) Apply Yes filter

Authorisation status

Authorised (414) Apply Authorised filter Refused (16) Apply Refused filter Withdrawn (64) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Negative (2) Apply Negative filter Positive (15) Apply Positive filter

Application type

Initial authorisation (11) Apply Initial authorisation filter Post-authorisation (6) Apply Post-authorisation filter

Withdrawal type

Initial authorisation (71) Apply Initial authorisation filter Post-authorisation (4) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (10) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (89) Apply PM: decision on the application for modification of an agreed PIP filter W: decision granting a waiver in all age groups for all conditions or indications (20) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (27) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (248) Apply Positive filter Withdrawn (8) Apply Withdrawn filter

Referral name

Referral status

European Commission final decision (6) Apply European Commission final decision filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes (3) Apply Yes filter

Referral type

Article 20 procedures (4) Apply Article 20 procedures filter Article 31 referrals (3) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (4) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (3) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (4) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (3) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Conditional approval Remove Conditional approval filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Additional monitoring (723) Apply Additional monitoring filter Biosimilar (99) Apply Biosimilar filter Exceptional circumstances (81) Apply Exceptional circumstances filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

969 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Summaries of opinion Remove Summaries of opinion filter

Categories Human Remove Human filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter Conditional approval Remove Conditional approval filter Orphan medicine Remove Orphan medicine filter

Sort by

List item

Human medicine European public assessment report (EPAR): Efavirenz Teva (updated)

efavirenz, HIV Infections
Date of authorisation: 09/01/2012, , Revision: 12, Authorised, Last updated: 03/03/2023
List item

Human medicine European public assessment report (EPAR): Pemazyre (updated)

pemigatinib, Cholangiocarcinoma
Date of authorisation: 26/03/2021, , , , Revision: 5, Authorised, Last updated: 02/03/2023
List item

Human medicine European public assessment report (EPAR): Scemblix (updated)

asciminib hydrochloride, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 25/08/2022, , , Revision: 2, Authorised, Last updated: 02/03/2023
List item

Human medicine European public assessment report (EPAR): Maviret (updated)

glecaprevir, pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017, , Revision: 21, Authorised, Last updated: 02/03/2023
List item

Human medicine European public assessment report (EPAR): Vyndaqel (updated)

tafamidis, Amyloidosis
Date of authorisation: 16/11/2011, , , , Revision: 25, Authorised, Last updated: 02/03/2023
List item

Human medicine European public assessment report (EPAR): Revestive (updated)

teduglutide, Malabsorption Syndromes
Date of authorisation: 30/08/2012, , , Revision: 21, Authorised, Last updated: 01/03/2023
List item

Human medicine European public assessment report (EPAR): Lenvima

lenvatinib mesilate, Thyroid Neoplasms
Date of authorisation: 28/05/2015, , , Revision: 17, Authorised, Last updated: 28/02/2023
List item

Human medicine European public assessment report (EPAR): Onpattro

patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018, , , , Revision: 10, Authorised, Last updated: 28/02/2023
List item

Human medicine European public assessment report (EPAR): Hemgenix

etranacogene dezaparvovec, Hemophilia B
Date of authorisation: 20/02/2023, , , , Authorised, Last updated: 28/02/2023
List item

Human medicine European public assessment report (EPAR): Temozolomide Hexal

temozolomide, Glioma; Glioblastoma
Date of authorisation: 15/03/2010, , Revision: 17, Withdrawn, Last updated: 27/02/2023
List item

Human medicine European public assessment report (EPAR): Dovprela (previously Pretomanid FGK)

Pretomanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 31/07/2020, , , , Revision: 7, Authorised, Last updated: 24/02/2023
List item

Human medicine European public assessment report (EPAR): Telmisartan Actavis

telmisartan, Hypertension
Date of authorisation: 29/09/2010, , Revision: 11, Authorised, Last updated: 24/02/2023
List item

Human medicine European public assessment report (EPAR): Fulvestrant Mylan

fulvestrant, Breast Neoplasms
Date of authorisation: 08/01/2018, , Revision: 5, Authorised, Last updated: 24/02/2023
List item

Human medicine European public assessment report (EPAR): Vizarsin

sildenafil, Erectile Dysfunction
Date of authorisation: 21/09/2009, , Revision: 19, Authorised, Last updated: 24/02/2023
List item

Human medicine European public assessment report (EPAR): Qinlock

ripretinib, Gastrointestinal Stromal Tumors
Date of authorisation: 18/11/2021, , , Revision: 2, Authorised, Last updated: 23/02/2023
List item

Human medicine European public assessment report (EPAR): Rasagiline Mylan

rasagiline tartrate, Parkinson Disease
Date of authorisation: 04/04/2016, , Revision: 7, Authorised, Last updated: 23/02/2023
List item

Human medicine European public assessment report (EPAR): Anagrelide Mylan

Anagrelide hydrochloride, Thrombocythemia, Essential
Date of authorisation: 15/02/2018, , Revision: 7, Authorised, Last updated: 23/02/2023
List item

Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)

dinutuximab beta, Neuroblastoma
Date of authorisation: 08/05/2017, , , , Revision: 13, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Azacitidine Mylan

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 27/03/2020, , Revision: 5, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Zalasta

olanzapine, Schizophrenia; Bipolar Disorder
Date of authorisation: 27/09/2007, , Revision: 20, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Pemetrexed Krka

pemetrexed disodium, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 22/05/2018, , Revision: 6, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Lamzede

velmanase alfa, alpha-Mannosidosis
Date of authorisation: 23/03/2018, , , , Revision: 6, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Natpar

parathyroid hormone, Hypoparathyroidism
Date of authorisation: 24/04/2017, , , , Revision: 14, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Nimvastid

rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 11/05/2009, , Revision: 10, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Tolura

telmisartan, Hypertension
Date of authorisation: 04/06/2010, , Revision: 11, Authorised, Last updated: 22/02/2023